Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Effects of Pramlintide on Weight Reduction in Clozapine- and Olanzapine-Induced Weight Gain in Obese People Diagnosed With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
910
mi
from 43215
Dallas, TX
Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Effects of Pramlintide on Weight Reduction in Clozapine- and Olanzapine-Induced Weight Gain in Obese People Diagnosed With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Cognitive Behavioral Therapy (CBT) for Nightmares in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans
CBT for Nightmares in OEF/OIF Veterans
Status: Enrolling
Updated:  12/31/1969
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
414
mi
from 43215
Philadelphia, PA
Cognitive Behavioral Therapy (CBT) for Nightmares in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans
CBT for Nightmares in OEF/OIF Veterans
Status: Enrolling
Updated: 12/31/1969
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Intensive Intervention for Toddlers With Autism (EARLY STEPS)
Intensive Intervention for Toddlers With Autism
Status: Enrolling
Updated:  12/31/1969
UC Davis MIND Institute
2042
mi
from 43215
Sacramento, CA
Intensive Intervention for Toddlers With Autism (EARLY STEPS)
Intensive Intervention for Toddlers With Autism
Status: Enrolling
Updated: 12/31/1969
UC Davis MIND Institute
2042
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans
Impact of Group Motivational Interviewing for Dually Diagnosed Veterans
Status: Enrolling
Updated:  12/31/1969
Ralph H. Johnson VA Medical Center, Charleston, SC
525
mi
from 43215
Charleston, SC
Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans
Impact of Group Motivational Interviewing for Dually Diagnosed Veterans
Status: Enrolling
Updated: 12/31/1969
Ralph H. Johnson VA Medical Center, Charleston, SC
525
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Cannabinoids, Neural Synchrony, and Information Processing
Cannabinoids, Psychosis, Neural Synchrony, and Information Processing
Status: Enrolling
Updated:  12/31/1969
VA Connecticut Healthcare System
535
mi
from 43215
West Haven, CT
Cannabinoids, Neural Synchrony, and Information Processing
Cannabinoids, Psychosis, Neural Synchrony, and Information Processing
Status: Enrolling
Updated: 12/31/1969
VA Connecticut Healthcare System
535
mi
from 43215
West Haven, CT
Click here to add this to my saved trials
Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain
The Attenuation of Second Generation Antipsychotic Induced Weight Gain in Adolescents and Adults Using Betahistine: A Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Nathan Kline Insitute for Psychiatric Research
481
mi
from 43215
Orangeburg, NY
Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain
The Attenuation of Second Generation Antipsychotic Induced Weight Gain in Adolescents and Adults Using Betahistine: A Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Nathan Kline Insitute for Psychiatric Research
481
mi
from 43215
Orangeburg, NY
Click here to add this to my saved trials
CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
CASPALLO: A Phase I Study Evaluating the Use of Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene After Haploidentical Stem Cell Transplantation
Status: Enrolling
Updated:  12/31/1969
Texas Children's Hospital
995
mi
from 43215
Houston, TX
CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
CASPALLO: A Phase I Study Evaluating the Use of Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene After Haploidentical Stem Cell Transplantation
Status: Enrolling
Updated: 12/31/1969
Texas Children's Hospital
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
CASPALLO: A Phase I Study Evaluating the Use of Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene After Haploidentical Stem Cell Transplantation
Status: Enrolling
Updated:  12/31/1969
Methodist Hospital
995
mi
from 43215
Houston, TX
CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
CASPALLO: A Phase I Study Evaluating the Use of Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene After Haploidentical Stem Cell Transplantation
Status: Enrolling
Updated: 12/31/1969
Methodist Hospital
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia
Neurophysiology of Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Dyslexia: Functional Magnetic Resonance Imaging (fMRI) Measures of Brain Activation During Attention and Reading Tasks Pre- and Post-Atomoxetine Treatment
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia
Neurophysiology of Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Dyslexia: Functional Magnetic Resonance Imaging (fMRI) Measures of Brain Activation During Attention and Reading Tasks Pre- and Post-Atomoxetine Treatment
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Healthy Activities for Prize Incentives
Healthy Activities for Prize Incentives
Status: Enrolling
Updated:  12/31/1969
Connections, Inc.
554
mi
from 43215
Hartford, CT
Healthy Activities for Prize Incentives
Healthy Activities for Prize Incentives
Status: Enrolling
Updated: 12/31/1969
Connections, Inc.
554
mi
from 43215
Hartford, CT
Click here to add this to my saved trials
Clinical Neurobiology of Serotonin and Addiction
Project 1: Clinical Neurobiology of Serotonin and Addiction
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center-Houston; Substance Abuse Research Clinic
995
mi
from 43215
Houston, TX
Clinical Neurobiology of Serotonin and Addiction
Project 1: Clinical Neurobiology of Serotonin and Addiction
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center-Houston; Substance Abuse Research Clinic
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Women Veterans' Substance Abuse Treatment
A Randomized Controlled Trial on Women's Substance Abuse Treatment
Status: Enrolling
Updated:  12/31/1969
Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA
634
mi
from 43215
Bedford, MA
Women Veterans' Substance Abuse Treatment
A Randomized Controlled Trial on Women's Substance Abuse Treatment
Status: Enrolling
Updated: 12/31/1969
Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA
634
mi
from 43215
Bedford, MA
Click here to add this to my saved trials
Women Veterans' Substance Abuse Treatment
A Randomized Controlled Trial on Women's Substance Abuse Treatment
Status: Enrolling
Updated:  12/31/1969
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
643
mi
from 43215
Boston, MA
Women Veterans' Substance Abuse Treatment
A Randomized Controlled Trial on Women's Substance Abuse Treatment
Status: Enrolling
Updated: 12/31/1969
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study
Lis-dexamphetamine (LDX/SPD489)as a Treatment for Smoking Cessation in Nicotine Dependent Individuals With ADHD
Status: Enrolling
Updated:  12/31/1969
Duke Attention Deficit Hyperactivity Disorder (ADHD) Program
mi
from 43215
Durham, NC
Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study
Lis-dexamphetamine (LDX/SPD489)as a Treatment for Smoking Cessation in Nicotine Dependent Individuals With ADHD
Status: Enrolling
Updated: 12/31/1969
Duke Attention Deficit Hyperactivity Disorder (ADHD) Program
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Effectiveness of Three Different Psychotherapies for Chronic Post-Traumatic Stress Disorder
Psychotherapies for Chronic Post-Traumatic Stress Disorder
Status: Enrolling
Updated:  12/31/1969
New York State Psychiatric Institute
481
mi
from 43215
New York, NY
Effectiveness of Three Different Psychotherapies for Chronic Post-Traumatic Stress Disorder
Psychotherapies for Chronic Post-Traumatic Stress Disorder
Status: Enrolling
Updated: 12/31/1969
New York State Psychiatric Institute
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
CSP #566 - Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
Status: Enrolling
Updated:  12/31/1969
CERC (VISN1, West Haven, CT)
535
mi
from 43215
West Haven, CT
Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
CSP #566 - Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
Status: Enrolling
Updated: 12/31/1969
CERC (VISN1, West Haven, CT)
535
mi
from 43215
West Haven, CT
Click here to add this to my saved trials
Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
CSP #566 - Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Jamaica Plain Campus
643
mi
from 43215
Boston, MA
Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
CSP #566 - Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Jamaica Plain Campus
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
CSP #566 - Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Jamaica Plain Campus
643
mi
from 43215
Boston, MA
Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
CSP #566 - Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Jamaica Plain Campus
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
CSP #566 - Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
Status: Enrolling
Updated:  12/31/1969
VA Puget Sound Health Care System, Seattle
2006
mi
from 43215
Seattle, WA
Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
CSP #566 - Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
Status: Enrolling
Updated: 12/31/1969
VA Puget Sound Health Care System, Seattle
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
CSP #566 - Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
Status: Enrolling
Updated:  12/31/1969
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
643
mi
from 43215
Boston, MA
Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
CSP #566 - Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study
Status: Enrolling
Updated: 12/31/1969
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome
Understanding the Anatomy and Physiology of the Sensory Experience and Its Role in Generating Tics in Tourette Syndrome
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome
Understanding the Anatomy and Physiology of the Sensory Experience and Its Role in Generating Tics in Tourette Syndrome
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Varenicline and Motivational Advice for Smokers With Substance Use Disorders
Varenicline and Motivational Advice for Smokers With SUD
Status: Enrolling
Updated:  12/31/1969
Brown University, Center for Alcohol and Addiction Studies
619
mi
from 43215
Providence, RI
Varenicline and Motivational Advice for Smokers With Substance Use Disorders
Varenicline and Motivational Advice for Smokers With SUD
Status: Enrolling
Updated: 12/31/1969
Brown University, Center for Alcohol and Addiction Studies
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Gender and Neural Substrates of Stress and Craving
Exploring Gender Differences in the Neural Substrates of Stress Induced Drug Craving
Status: Enrolling
Updated:  12/31/1969
Clinical Neurosciences Division-Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Gender and Neural Substrates of Stress and Craving
Exploring Gender Differences in the Neural Substrates of Stress Induced Drug Craving
Status: Enrolling
Updated: 12/31/1969
Clinical Neurosciences Division-Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia
Safety of Transcranial Direct Current Brain Stimulation (TDCS) for Improvement of Psychotic Symptoms and Cognitive Functioning in Childhood Onset Schizophrenia (COS)
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia
Safety of Transcranial Direct Current Brain Stimulation (TDCS) for Improvement of Psychotic Symptoms and Cognitive Functioning in Childhood Onset Schizophrenia (COS)
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
A Trial of SAMe for Treatment-Resistant Bipolar Depression
Intermittent-Dose Oral SAMe (S-adenosyl-L-methionine) in Persistent and Treatment-Refractory Bipolar Depression: A Double-Blind Pilot Trial With an Optional Open-label Follow-up
Status: Enrolling
Updated:  12/31/1969
McLean Hospital
637
mi
from 43215
Belmont, MA
A Trial of SAMe for Treatment-Resistant Bipolar Depression
Intermittent-Dose Oral SAMe (S-adenosyl-L-methionine) in Persistent and Treatment-Refractory Bipolar Depression: A Double-Blind Pilot Trial With an Optional Open-label Follow-up
Status: Enrolling
Updated: 12/31/1969
McLean Hospital
637
mi
from 43215
Belmont, MA
Click here to add this to my saved trials
Modeling Stress-precipitated Smoking Behavior for Medication Development
Modeling Stress-precipitated Smoking Behavior for Medication Development
Status: Enrolling
Updated:  12/31/1969
Yale Center for Clinical Investigation, Yale University
537
mi
from 43215
New Haven, CT
Modeling Stress-precipitated Smoking Behavior for Medication Development
Modeling Stress-precipitated Smoking Behavior for Medication Development
Status: Enrolling
Updated: 12/31/1969
Yale Center for Clinical Investigation, Yale University
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated:  12/31/1969
Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia
451
mi
from 43215
Augusta, GA
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated: 12/31/1969
Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia
451
mi
from 43215
Augusta, GA
Click here to add this to my saved trials
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated:  12/31/1969
Dana Farber Cancer Institute Hematology / Oncology
643
mi
from 43215
Boston, MA
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated: 12/31/1969
Dana Farber Cancer Institute Hematology / Oncology
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated:  12/31/1969
University of Michigan Comprehensive Cancer Center DeptofMichiganCancerCenter(3)
167
mi
from 43215
Ann Arbor, MI
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated: 12/31/1969
University of Michigan Comprehensive Cancer Center DeptofMichiganCancerCenter(3)
167
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center Dept. of MSKCC (2)
478
mi
from 43215
New York, NY
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center Dept. of MSKCC (2)
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated:  12/31/1969
Oregon Health & Science University Dept. Hematologic Malignancies
2026
mi
from 43215
Portland, OR
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated: 12/31/1969
Oregon Health & Science University Dept. Hematologic Malignancies
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University SC
344
mi
from 43215
Richmond, VA
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University SC
344
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles Dept. of Hematology Clinic
1982
mi
from 43215
Los Angeles, CA
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles Dept. of Hematology Clinic
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated:  12/31/1969
Stanford University Medical Center Stanford Univ 2
2101
mi
from 43215
Stanford, CA
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated: 12/31/1969
Stanford University Medical Center Stanford Univ 2
2101
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
9459
mi
from 43215
Camperdown,
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
9459
mi
from 43215
Camperdown,
Click here to add this to my saved trials
Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer
A Phase I/II Study Evaluating the Safety and Efficacy of Adding a Single Prophylactic Donor Lymphocyte Infusion (DLI) of Natural Killer Cells Early After Nonmyeloablative, HLA-Haploidentical Hematopoietic Cell Transplantation - A Multi Center Trial
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Wisconsin
335
mi
from 43215
Milwaukee, WI
Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer
A Phase I/II Study Evaluating the Safety and Efficacy of Adding a Single Prophylactic Donor Lymphocyte Infusion (DLI) of Natural Killer Cells Early After Nonmyeloablative, HLA-Haploidentical Hematopoietic Cell Transplantation - A Multi Center Trial
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Wisconsin
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer
A Phase I/II Study Evaluating the Safety and Efficacy of Adding a Single Prophylactic Donor Lymphocyte Infusion (DLI) of Natural Killer Cells Early After Nonmyeloablative, HLA-Haploidentical Hematopoietic Cell Transplantation - A Multi Center Trial
Status: Enrolling
Updated:  12/31/1969
Froedtert and the Medical College of Wisconsin
335
mi
from 43215
Milwaukee, WI
Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer
A Phase I/II Study Evaluating the Safety and Efficacy of Adding a Single Prophylactic Donor Lymphocyte Infusion (DLI) of Natural Killer Cells Early After Nonmyeloablative, HLA-Haploidentical Hematopoietic Cell Transplantation - A Multi Center Trial
Status: Enrolling
Updated: 12/31/1969
Froedtert and the Medical College of Wisconsin
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer
A Phase I/II Study Evaluating the Safety and Efficacy of Adding a Single Prophylactic Donor Lymphocyte Infusion (DLI) of Natural Killer Cells Early After Nonmyeloablative, HLA-Haploidentical Hematopoietic Cell Transplantation - A Multi Center Trial
Status: Enrolling
Updated:  12/31/1969
Fred Hutch/University of Washington Cancer Consortium
2003
mi
from 43215
Seattle, WA
Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer
A Phase I/II Study Evaluating the Safety and Efficacy of Adding a Single Prophylactic Donor Lymphocyte Infusion (DLI) of Natural Killer Cells Early After Nonmyeloablative, HLA-Haploidentical Hematopoietic Cell Transplantation - A Multi Center Trial
Status: Enrolling
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
2003
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
A Controlled Trial of Citalopram Added to Methylphenidate in Youth With Severe Mood Dysregulation
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
A Controlled Trial of Citalopram Added to Methylphenidate in Youth With Severe Mood Dysregulation
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Behavioral Activation for PTSD/Depression Treatment in OIF/OEF Veterans
Behavioral Activation for PTSD, Depression Treatment in OIF/OEF Veterans
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Portland
2027
mi
from 43215
Portland, OR
Behavioral Activation for PTSD/Depression Treatment in OIF/OEF Veterans
Behavioral Activation for PTSD, Depression Treatment in OIF/OEF Veterans
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Portland
2027
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Behavioral Activation for PTSD/Depression Treatment in OIF/OEF Veterans
Behavioral Activation for PTSD, Depression Treatment in OIF/OEF Veterans
Status: Enrolling
Updated:  12/31/1969
VA Puget Sound Health Care System, Seattle
2006
mi
from 43215
Seattle, WA
Behavioral Activation for PTSD/Depression Treatment in OIF/OEF Veterans
Behavioral Activation for PTSD, Depression Treatment in OIF/OEF Veterans
Status: Enrolling
Updated: 12/31/1969
VA Puget Sound Health Care System, Seattle
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Contingency Management for Smoking in Substance Abusers
Contingent Vouchers for Smoking in Substance Abusers as Adjunct to Nicotine Patch
Status: Enrolling
Updated:  12/31/1969
Brown University, Center for Alcohol and Addiction Studies
619
mi
from 43215
Providence, RI
Contingency Management for Smoking in Substance Abusers
Contingent Vouchers for Smoking in Substance Abusers as Adjunct to Nicotine Patch
Status: Enrolling
Updated: 12/31/1969
Brown University, Center for Alcohol and Addiction Studies
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse
Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse With Methadone Maintained Individuals
Status: Enrolling
Updated:  12/31/1969
Kinsella Treatment Center (KTC)
522
mi
from 43215
Bridgeport, CT
Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse
Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse With Methadone Maintained Individuals
Status: Enrolling
Updated: 12/31/1969
Kinsella Treatment Center (KTC)
522
mi
from 43215
Bridgeport, CT
Click here to add this to my saved trials
Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse
Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse With Methadone Maintained Individuals
Status: Enrolling
Updated:  12/31/1969
Regional Network of Programs
525
mi
from 43215
Stratford, CT
Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse
Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse With Methadone Maintained Individuals
Status: Enrolling
Updated: 12/31/1969
Regional Network of Programs
525
mi
from 43215
Stratford, CT
Click here to add this to my saved trials
Study of Gulf War Illness (GWI) by Comparing GWI and Healthy Veterans
CNDP1 Polymorphisms in Gulf War Illness (GWI)
Status: Enrolling
Updated:  12/31/1969
Georgetown University
328
mi
from 43215
Washington,
Study of Gulf War Illness (GWI) by Comparing GWI and Healthy Veterans
CNDP1 Polymorphisms in Gulf War Illness (GWI)
Status: Enrolling
Updated: 12/31/1969
Georgetown University
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI)
Carnosine Versus Placebo Treatment Study in Gulf War Illness (GWI)
Status: Enrolling
Updated:  12/31/1969
Georgetown University
328
mi
from 43215
Washington,
Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI)
Carnosine Versus Placebo Treatment Study in Gulf War Illness (GWI)
Status: Enrolling
Updated: 12/31/1969
Georgetown University
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Effectiveness of a Parent Training Program for Parents of Children Adopted Internationally
Early Intervention for Children Adopted Internationally
Status: Enrolling
Updated:  12/31/1969
University of Delaware
395
mi
from 43215
Newark, DE
Effectiveness of a Parent Training Program for Parents of Children Adopted Internationally
Early Intervention for Children Adopted Internationally
Status: Enrolling
Updated: 12/31/1969
University of Delaware
395
mi
from 43215
Newark, DE
Click here to add this to my saved trials
Telemedicine Outreach for Post Traumatic Stress in CBOCs
Telemedicine Outreach for Post Traumatic Stress in CBOCs
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Loma Linda
1831
mi
from 43215
Loma Linda, CA
Telemedicine Outreach for Post Traumatic Stress in CBOCs
Telemedicine Outreach for Post Traumatic Stress in CBOCs
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Loma Linda
1831
mi
from 43215
Loma Linda, CA
Click here to add this to my saved trials
Telemedicine Outreach for Post Traumatic Stress in CBOCs
Telemedicine Outreach for Post Traumatic Stress in CBOCs
Status: Enrolling
Updated:  12/31/1969
Overton Brooks VA Medical Center, Shreveport, LA
787
mi
from 43215
Shreveport, LA
Telemedicine Outreach for Post Traumatic Stress in CBOCs
Telemedicine Outreach for Post Traumatic Stress in CBOCs
Status: Enrolling
Updated: 12/31/1969
Overton Brooks VA Medical Center, Shreveport, LA
787
mi
from 43215
Shreveport, LA
Click here to add this to my saved trials